|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.37 USD | +8.33% |
|
+0.83% | +6.66% |
| 07-17 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
| 07-04 | Certain Common Stock of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. | CI |
Quotes 5-day view: Avalo Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-07-13 | 2026-07-14 | 2026-07-15 | 2026-07-16 | 2026-07-17 | |
|---|---|---|---|---|---|
| Last | US$18.91 | US$18.42 | US$18.55 | US$17.88 | US$19.37 |
| Volume | 698,847 | 850,695 | 618,040 | 1,269,534 | 1,244,919 |
| Change | -1.56% | -2.59% | +0.71% | -3.61% | +8.33% |
| Opening | US$18.93 | US$19.05 | US$18.22 | US$18.33 | US$17.79 |
| High | US$18.95 | US$19.12 | US$18.70 | US$18.89 | US$19.49 |
| Low | US$18.08 | US$18.34 | US$18.05 | US$17.78 | US$17.54 |
Performance
| 1 day | +8.33% | ||
| 1 week | +0.83% | ||
| Current month | +4.82% | ||
| 1 month | +25.78% | ||
| 3 months | +34.23% | ||
| 6 months | +28.62% | ||
| Current year | +6.66% | ||
| 1 year | +242.23% | ||
| 3 years | -76.61% | ||
| 5 years | -99.76% | ||
| 10 years | -99.71% |
Volumes
marketsDaily volume
1,244,919
Estimated daily volume
1,244,919
Avg. Volume 20 sessions
1,848,749
Daily volume ratio
0.67
Avg. Volume 20 sessions USD
35,810,268.13
Record volume 1
31,910,412
Record volume 2
22,460,588
Record volume 3
8,576,599
Capital turnover ratio
0.04
Float rotation
0.04
Basic data
Market Cap (USD)
1,018,195,129
Net sales (USD)
59,000
Number of employees
33
Sales / Employee (USD)
1,788
Free-Float
98.27 %
Free-Float capitalization (USD)
1,000,585,726
Average Daily Capital Traded
3.52%
Indicators
Moving average 5 days
18.63
Moving average 20 days
18.23
Moving average 50 days
17.11
Moving average 100 days
16.2
Price spread / (MMA5)
-3.84%
Price spread / (MMA20)
-5.88%
Price spread / (MMA50)
-11.64%
Price spread / (MMA100)
-16.34%
RSI 9 days
46.63
RSI 14 days
51.04
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | +0.83% | +242.23% | -76.61% | 1.02B | |
| -7.17% | -4.39% | +45.51% | +79.00% | 52.1B | |
| +0.24% | -1.54% | +53.22% | +71.85% | 53.83B | |
| +0.80% | -6.31% | +3.98% | +423.29% | 23.48B | |
| -0.09% | -0.01% | -17.62% | -14.67% | 23.13B | |
| -5.95% | -2.58% | +30.67% | -9.58% | 19.36B | |
| -1.14% | +0.03% | +31.57% | -30.42% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +306.37% | 15.2B | |
| -6.91% | -5.83% | +26.53% | +636.97% | 14.83B | |
| +0.43% | -1.03% | +24.63% | +191.40% | 14.06B | |
| Average | -1.66% | -2.28% | +60.92% | +157.76% | 23.46B | |
| Weighted average by Cap. | -2.75% | -2.34% | +41.00% | +143.15% |
Historical Quotes: Avalo Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
4e6f65ed8d3.ajC37mkZVzuQNjr1pshfRcAGkODYgZ5DaAsn7kQDX5o.EmPdjBh6O3_eYFSD6oMUMIc_pqOd8up0X2BWtgd7b_Q9BNC2MUEgWtFpDg
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 19.37 | 106,531 | 973,961 |
| 15:59:58 | 19.38 | 100 | 867,430 |
| 15:59:57 | 19.38 | 1,553 | 867,330 |
| 15:59:57 | 19.37 | 100 | 865,777 |
| 15:59:56 | 19.39 | 200 | 865,677 |
| 15:59:56 | 19.38 | 100 | 865,477 |
| 15:59:56 | 19.39 | 100 | 865,377 |
| 15:59:56 | 19.39 | 147 | 865,277 |
| 15:59:55 | 19.36 | 120 | 865,130 |
| 15:59:55 | 19.36 | 120 | 865,010 |
Course Extremes
| 1 week | 17.54 |  | 19.48 |
| 1 month | 14.71 | | 20.65 |
| Current year | 12.51 | | 24.27 |
| 1 year | 6.21 | | 24.27 |
| 3 years | 3.39 | | 79.2 |
| 5 years | 3.39 | | 9,331.13 |
| 10 years | 3.39 | | 22,031.54 |
Monthly variations
Annual variations
| 2026 | +6.66% | ||
| 2025 | +144.41% | ||
| 2024 | -18.35% | ||
| 2023 | -99.25% | ||
| 2022 | -75.29% | ||
| 2021 | -35.61% | ||
| 2020 | -51.02% | ||
| 2019 | +66.87% | ||
| 2018 | +0.94% | ||
| 2017 | +263.47% | ||
| 2016 | -73.72% | ||
| 2015 | -16.25% |
- Stock Market
- Stocks
- AVTX Stock
- Quotes Avalo Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
